English Spanish Chinese Russian German Japanese Portuguese Hindi Telugu Tamil

Archives de médecine

  • ISSN: 1989-5216
  • Indice h du journal: 22
  • Note de citation du journal: 4.96
  • Facteur d’impact du journal: 4.44
Indexé dans
  • Genamics JournalSeek
  • Infrastructure nationale des connaissances en Chine (CNKI)
  • Répertoire d'indexation des revues de recherche (DRJI)
  • OCLC - WorldCat
  • Invocation de Proquête
  • Publions
  • Fondation genevoise pour la formation et la recherche médicales
  • Pub européen
  • Google Scholar
  • Laboratoires secrets des moteurs de recherche
Voir plus
Partager cette page

Abstrait

Prevalence of Depression among Hospital Based Rheumatoid Arthritis Population and its Associated Factors

Heba Samy Shoukry

Background: Depression is of high prevalence among rheumatoid arthritis patients compromising the physical and psychological aspects of quality of life. It is highly associated with VIT D level.

Patients and methods: This study included 200 RA patients. (BDI) was used to detect depression. Disease activity was measured using disease activity score (DAS-28) and Rheumatoid Arthritis Disease Activity Index (RADAI-5). The Modified Health Assessment Questionnaire (MHAQ) was used for measuring disability. Rheumatoid Arthritis Quality of Life scale (RAQoL), Visual Analogue Score-pain (VAS-pain), and Fatigue Severity Scale (FSS) scores were calculated.

Results: The mean disease duration 6.75 ± 4.32 years, 69.5% were females and 30.5% males (F: M 2.27:1). Their mean DAS-28 was 3.97 ± 1.19 and MHAQ 1.27 ± 0.63. The mean BDI II score was 21 ± 12.61. 48.5% of the patients had moderate depression 4.5% had severe depression. BDI II significantly correlated with erythrocyte sedimentation rate, C-reactive protein, DAS-28, MHAQ, RAQoL VAS-pain FSS and RADAI (p=0.001).

Conclusion: Depression is highly prevalent among rheumatoid arthritis patients. Screening for depression periodically in RA should be included management protocols to avoid poor outcomes.